IRVINE, Calif.—Jinan Asia Pharmaceutical (JAP) opened an office in Irvine, California and introduced the newly formed HL-Pharma USA Corporation. JAP is one of the global leaders in producing Choline, Betaine and their derivatives. HL-Pharma, located in Irvine California, will act as JAP’s exclusive U.S. representative North America.
According to the U.S. Customs Department, over 800 metric tons of Choline was imported into the U.S. in 2013, of which JAP enjoyed greater than a 30 percent market share.
Earlier this year, JAP signed an exclusive partnership with GWI.
0 comments
Hide comments